UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5

BMC cancer, 2017-09, Vol.17 (1), p.631-631, Article 631

2017

Volltextzugriff (PDF)

Role of CYP3A5 in Modulating Androgen Receptor Signaling and Its Relevance to African American Men with Prostate Cancer

Cancers, 2020-04, Vol.12 (4), p.989

2020

Volltextzugriff (PDF)

Neprilysin Inhibits Angiogenesis via Proteolysis of Fibroblast Growth Factor-2

The Journal of biological chemistry, 2006-11, Vol.281 (44), p.33597-33605

2006

Volltextzugriff (PDF)

CYP3A5 regulates prostate cancer cell growth by facilitating nuclear translocation of AR

The Prostate, 2015-04, Vol.75 (5), p.527-538

2015

Volltextzugriff (PDF)

Neutral endopeptidase is a myristoylated protein

Molecular and cellular biochemistry, 2010-02, Vol.335 (1-2), p.173-180

2010

Volltextzugriff (PDF)

Circulating Tumor Cells in Patients with Castration-Resistant Prostate Cancer Baseline Values and Correlation with Prognostic Factors

Cancer epidemiology, biomarkers & prevention, 2009-06, Vol.18 (6), p.1904-1913

2009

Volltextzugriff (PDF)

A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma

European urology oncology, 2024-08, Vol.7 (4), p.933-943

2024

Volltextzugriff (PDF)

Abiraterone and Increased Survival in Metastatic Prostate Cancer

The New England journal of medicine, 2011-05, Vol.364 (21), p.1995-2005

2011

Volltextzugriff (PDF)

Synergistic loss of prostate cancer cell viability by coinhibition of HDAC and PARP

Molecular cancer research, 2014-12, Vol.12 (12), p.1755-1766

2014

Volltextzugriff (PDF)

DNA‐PKc inhibition overcomes taxane resistance by promoting taxane‐induced DNA damage in prostate cancer cells

The Prostate, 2021-10, Vol.81 (14), p.1032-1048

2021

Volltextzugriff (PDF)

Is there a role for LHRH antagonists in prostate cancer?

Oncology (Williston Park, N.Y.), 2009-06, Vol.23 (7), p.632, 635-635

Goodman, Jr, Oscar B

2009

Volltextzugriff (PDF)

A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors

Investigational new drugs, 2018-12, Vol.36 (6), p.1060-1071

2018

Volltextzugriff (PDF)

Comparison of Circulating MicroRNA 141 to Circulating Tumor Cells, Lactate Dehydrogenase, and Prostate-Specific Antigen for Determining Treatment Response in Patients With Metastatic Prostate Cancer

Clinical genitourinary cancer, 2011-09, Vol.9 (1), p.39-45

2011

Volltextzugriff (PDF)

Circulating Tumor Cells as a Predictive Biomarker in Patients With Hormone-sensitive Prostate Cancer

Clinical genitourinary cancer, 2011-09, Vol.9 (1), p.31-38

2011

Volltextzugriff (PDF)

The relevance of BRCA genetics to prostate cancer pathogenesis and treatment

Clinical advances in hematology & oncology, 2011-10, Vol.9 (10), p.748-755

2011

Volltextzugriff (PDF)

Bombesin attenuates pre-mRNA splicing of glucocorticoid receptor by regulating the expression of serine-arginine protein p30c (SRp30c) in prostate cancer cells

Biochimica et biophysica acta, 2007-07, Vol.1773 (7), p.1087-1094

2007

Volltextzugriff (PDF)

Urothelial Bladder Carcinoma With Choriocarcinomatous Differentiation Presenting With a False-Positive Pregnancy Test

The American journal of the medical sciences, 2013-09, Vol.346 (3), p.256-258

2013

Volltextzugriff (PDF)

Multiple androgen response elements cooperate in androgen regulated activity of the type 1 neutral endopeptidase promoter

Molecular and cellular endocrinology, 2006-10, Vol.259 (1), p.10-21

2006

Volltextzugriff (PDF)

Interaction of prostate specific membrane antigen with clathrin and the adaptor protein complex-2

International journal of oncology, 2007-11, Vol.31 (5), p.1199-1203

2007

Volltextzugriff (PDF)

Mapping of the molecular determinants involved in the interaction between eps15 and AP-2

Cancer research (Chicago, Ill.), 1997-01, Vol.57 (2), p.240-245

1997

Volltextzugriff (PDF)

Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literature

Journal of medical case reports, 2009-09, Vol.3 (1), p.9110-9110

2009

Volltextzugriff (PDF)

Novel Antibody Approaches for T-Cell Lymphomas

Clinical lymphoma & myeloma, 2008-12, Vol.8, p.S193-S198

2008

Volltextzugriff (PDF)

The Chain of the AP-2 Adaptor Is a Clathrin Binding Subunit

The Journal of biological chemistry, 1995-10, Vol.270 (40), p.23768

1995

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Humans
(23)
Male
(18)
Oncology
(14)
Prostate Cancer
(14)
Aged
(8)
Prostatic Neoplasms - Pathology
(8)
Biological And Medical Sciences
(7)
Middle Aged
(7)
Neoplasm Metastasis
(6)
Adult
(5)
Animals
(5)
Cell Line, Tumor
(5)
Female
(5)
Medical Sciences
(5)
Tumors
(5)
Urology & Nephrology
(5)
Aged, 80 And Over
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5

Role of CYP3A5 in Modulating Androgen Receptor Signaling and Its Relevance to African American Men with Prostate Cancer

Neprilysin Inhibits Angiogenesis via Proteolysis of Fibroblast Growth Factor-2

CYP3A5 regulates prostate cancer cell growth by facilitating nuclear translocation of AR

Neutral endopeptidase is a myristoylated protein

Circulating Tumor Cells in Patients with Castration-Resistant Prostate Cancer Baseline Values and Correlation with Prognostic Factors

A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma

Apalutamide plus abiraterone acetate and prednisone versus placebo plus abiraterone and prednisone in metastatic, castration-resistant prostate cancer (ACIS): a randomised, placebo-controlled, double-blind, multinational, phase 3 study

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

Abiraterone and Increased Survival in Metastatic Prostate Cancer

Synergistic loss of prostate cancer cell viability by coinhibition of HDAC and PARP

DNA‐PKc inhibition overcomes taxane resistance by promoting taxane‐induced DNA damage in prostate cancer cells

Is there a role for LHRH antagonists in prostate cancer?

A phase 1, first-in-human study of AMG 900, an orally administered pan-Aurora kinase inhibitor, in adult patients with advanced solid tumors

Comparison of Circulating MicroRNA 141 to Circulating Tumor Cells, Lactate Dehydrogenase, and Prostate-Specific Antigen for Determining Treatment Response in Patients With Metastatic Prostate Cancer

Circulating Tumor Cells as a Predictive Biomarker in Patients With Hormone-sensitive Prostate Cancer

The relevance of BRCA genetics to prostate cancer pathogenesis and treatment

Bombesin attenuates pre-mRNA splicing of glucocorticoid receptor by regulating the expression of serine-arginine protein p30c (SRp30c) in prostate cancer cells

Urothelial Bladder Carcinoma With Choriocarcinomatous Differentiation Presenting With a False-Positive Pregnancy Test

Multiple androgen response elements cooperate in androgen regulated activity of the type 1 neutral endopeptidase promoter

Interaction of prostate specific membrane antigen with clathrin and the adaptor protein complex-2

Mapping of the molecular determinants involved in the interaction between eps15 and AP-2

Carcinomatous meningitis in a patient with Her2/neu expressing bladder cancer following trastuzumab and chemotherapy: a case report and review of the literature

Novel Antibody Approaches for T-Cell Lymphomas

The Chain of the AP-2 Adaptor Is a Clathrin Binding Subunit

Suchergebnisse filtern